本文選題：甲氨蝶呤　切入點：藥物超敏反應綜合征　出處：《中國新藥雜志》2017年06期 　論文類型：期刊論文

【摘要】：目的:探討甲氨蝶呤致藥物過敏反應的臨床特點,為該藥的安全合理使用提供依據(jù)。方法:報道我院1例甲氨蝶呤致藥物超敏反應綜合征案例,并通過檢索Medline,CNKI,萬方、維普等數(shù)據(jù)庫,收集甲氨蝶呤致過敏反應相關(guān)文獻報道,進行統(tǒng)計分析。結(jié)果:綜合文獻及我院案例,共收集38例甲氨蝶呤致過敏反應病例,以18歲以下未成年患者居多,原發(fā)疾病以骨肉瘤和急性淋巴細胞白血病為主,給藥方式主要為靜脈滴注,臨床表現(xiàn)多為系統(tǒng)性過敏癥狀。除3例患者死亡外,其余均癥狀緩解,并有5例患者經(jīng)脫敏治療后繼續(xù)使用甲氨蝶呤。結(jié)論:甲氨蝶呤相關(guān)過敏反應發(fā)生率雖低但嚴重程度較高,臨床應用時需密切關(guān)注患者的病情變化,及時采取應對措施。對發(fā)生甲氨蝶呤過敏反應又須繼續(xù)用藥的患者,可嘗試脫敏治療。
[Abstract]:Objective: to investigate the clinical characteristics of methotrexate induced drug hypersensitivity, and to provide evidence for the safe and rational use of methotrexate. Methods: a case of methotrexate induced drug hypersensitivity syndrome was reported in our hospital. Results: a total of 38 cases of methotrexate induced allergic reaction were collected in our hospital. The primary diseases were osteosarcoma and acute lymphoblastic leukemia. The main way of administration was intravenous drip. The clinical manifestations were mostly systemic hypersensitivity. Five patients continued to use methotrexate after desensitization. Conclusion: the incidence of methotrexate related allergic reaction is low but the severity is high. Timely response. Patients with methotrexate hypersensitivity and need to continue medication, can try desensitization treatment.
【作者單位】： 北京大學人民醫(yī)院藥劑科;
【基金】：國家自然科學基金資助項目(81503050)
【分類號】：R977

【相似文獻】

相關(guān)期刊論文 前10條

1 張昆鵬;甲氨蝶呤在日本導致134例患者死亡[J];基層醫(yī)學論壇;2005年03期

2 賴毓冕;葉明;張秋實;黃薇;;甲氨蝶呤全身用藥成功治療剖宮產(chǎn)子宮瘢痕處妊娠[J];中華實用診斷與治療雜志;2009年03期

3 王敏;;甲氨蝶呤治療未破裂型異位妊娠分析[J];臨床合理用藥雜志;2009年03期

4 朱光華;周，

本文編號：1598896